|2.||Respiratory Tract Infections (Respiratory Tract Infection)
|5.||Wounds and Injuries (Trauma)
|1.||Falagas, Matthew E: 3 articles (01/2014 - 07/2008)|
|2.||Cazeneuve, J-F: 2 articles (02/2014 - 10/2006)|
|3.||Levin, A S: 2 articles (02/2014 - 03/2002)|
|4.||Cristofari, D-J: 2 articles (02/2014 - 10/2006)|
|5.||Tuna, Nazan: 2 articles (01/2014 - 04/2012)|
|6.||Gaughan, John: 2 articles (12/2011 - 08/2011)|
|7.||Eisenstein, Toby K: 2 articles (12/2011 - 08/2011)|
|8.||Breslow, Jessica M: 2 articles (12/2011 - 08/2011)|
|9.||Meissler, Joseph J: 2 articles (12/2011 - 08/2011)|
|10.||Prashanth, K: 2 articles (04/2009 - 04/2004)|
|1.||tigecycline (Tygacil)FDA Link
10/01/2008 - "Further clinical trials are needed to confirm the efficacy of tigecycline in the management of MDR Acinetobacter infections."
09/01/2008 - "Data from more studies are needed before tigecycline can be recommended for the treatment of Acinetobacter infections."
01/01/2014 - "The activity of tigecycline should be evaluated, as this is commonly used as last-resort option for the treatment of multidrug-resistant Acinetobacter infections."
04/01/2010 - "Clinical experience with tigecycline in the treatment of carbapenem-resistant Acinetobacter infections."
11/01/2008 - "Comment: tigecycline for the treatment of Acinetobacter infections: a case series."
|2.||Colistin (Coly-Mycin)FDA Link
08/01/2013 - "A total of 46 patients who had been administered intravenous colistin treatment for colistin-susceptible-only Acinetobacter infections were included in the study. "
08/01/2013 - "Impact of the initiation time of colistin treatment for Acinetobacter infections."
10/01/2009 - "Colistin has re-emerged as a highly effective antibiotic against multiresistant Pseudomonas and Acinetobacter infections. "
10/01/2009 - "Colistin has re-emerged as a highly effective antibiotic against multiresistant Pseudomonas and Acinetobacter infections of burns. "
09/11/2011 - "Antibiotic resistance of Acinetobacter baumannii and Pseudomonas infections showed a marked increase in 2010 when compared to that found in 2008: there was no multiresistant Acinetobacter infection in samples obtained in 2008, but all these infections were found to be sensitive only to colistin in samples investigated in 2010. "
|3.||sultamicillin (ampicillin-sulbactam)FDA LinkGeneric
04/01/2013 - "The objective of this study was to evaluate whether the outcomes of carbapenem-resistant Acinetobacter infections treated with ampicillin/sulbactam were associated with the in vitro susceptibility profiles. "
03/01/2002 - "Therefore, ampicillin-sulbactam is a sensible option for the treatment of life-threatening acinetobacter infections."
03/01/2002 - "Furthermore, ampicillin-sulbactam has proven clinically effective and well tolerated in the treatment of severe acinetobacter infections, including bacteremia. "
|4.||Anti-Bacterial Agents (Antibiotics)IBA
07/01/2005 - "Very few of the major antibiotics are now reliably effective for the treatment of severe nosocomial carbapenem-resistant Acinetobacter infections. "
01/01/2014 - "The susceptibility rates of the antibiotics that are mainly used in the treatment of Acinetobacter infections were compared by years. "
01/01/2014 - "The prevalence of Acinetobacter infections can be reduced by taking strict isolation measures as well as by implementing good antibiotics usage policy."
07/01/2011 - "This patient had several risk factors for Acinetobacter infection, including exposure to antibiotics and previous admission to a neonatal care unit; therefore, it was difficult to judge the import of the isolation of A. "
02/01/2011 - "However, Acinetobacter infections that are resistant to all commercially available antibiotics have been reported. "
03/01/2002 - "Multiresistant Acinetobacter infections: a role for sulbactam combinations in overcoming an emerging worldwide problem."
11/12/1994 - "Clinical and molecular epidemiology of acinetobacter infections sensitive only to polymyxin B and sulbactam."
04/01/2008 - "Since colistin which is one of the alternative antimicrobial treatment choices for resistant Acinetobacter infections, is not found in Turkey, sulbactam-ampicillin might be an effective and safe choice for the treatment of multi-resistant A. "
10/30/2012 - "[Cefoperazone-sulbactam plus minocycline in the treatment of extensively drug resistant Acinetobacter infections]."
|6.||Ampicillin (Omnipen)FDA LinkGeneric
|7.||Carbapenems (Carbapenem Antibiotics)IBA
01/01/2014 - "The aim of the present study was to evaluate the changes in the prevalence of Acinetobacter infection by restricting the consumption of carbapenems in intensive care unit patients. "
10/01/2014 - "Carbapenems are now the treatment of choice for Acinetobacter infections but their activity too is being eroded. "
09/19/2013 - "Dissemination of Acinetobacter baumannii strains harboring class D β-lactamases producing resistance to carbapenem antibiotics severely limits our ability to treat deadly Acinetobacter infections. "
04/01/2009 - "Carbapenems play a pivotal role in the management of severe Acinetobacter infections. "
02/01/1997 - "Novel derivatives of cephalosporins, carbapenems, fluoroquinolones, or completely new antibiotic classes, of which several investigational drugs seem promising, may constitute the future of antibiotic therapy and hence the treatment of Acinetobacter infections."
|8.||Amikacin (A.M.K)FDA LinkGeneric
07/01/1995 - "Multi-resistant Acinetobacter strains were isolated most frequently from the respiratory tract, and eight patients had probable or suspected pneumonia caused by a multi-resistant Acinetobacter sp. All infected patients were treated with imipenem, with or without an aminoglycoside, except one patient who died before a diagnosis of acinetobacter infection was confirmed. "
08/21/1993 - "Appropriate antibiotics for the initial treatment of suspected Acinetobacter infections include imipenem and carboxy- and ureidopenicillins combined with an aminoglycoside."
04/04/1990 - "It is concluded that imipenem is one of the major antibiotics available for the treatment of nosocomial Acinetobacter infections. "
06/01/1995 - "Acinetobacter infections are difficult to treat owing to their frequent multiple resistance to the antibiotics currently available for the treatment of nosocomial infections; various mechanisms of resistance to beta-lactams and amino-glycosides have been identified in the genus. "
02/01/1997 - "Over the last two decades the antibacterial armamentarium has progressed significantly and newer broad spectrum antibiotics have been used during therapy of hospital infections due to drug-resistant Acinetobacter spp. Despite various mechanisms of resistance to beta-lactams, aminoglycosides, fluoroquinolones developed by these organisms, the control of Acinetobacter infections can be effected by the use of several antibiotic combinations in 'conventional' antibiotic therapy. "
|1.||Neonatal Intensive Care
01/01/2015 - "This study was done on blood samples from neonates admitted to neonatal intensive care unit during a period of one year from January to December 2012, who developed Acinetobacter infection. "
01/01/2013 - "Therefore, an effective infection control policy and rational antibiotic use are mandatory in neonatal intensive care areas of each hospital in order to control Acinetobacter infection and improve outcome."
01/01/2013 - "A retrospective analysis was performed over a one and a half year period of all neonates admitted with sepsis in our neonatal intensive care unit (NICU), who developed Acinetobacter infection and to identify mortality-associated risk factors in these neonates. "
01/01/2010 - "We performed a retrospective chart review during a five-year period (July 2003 - June 2008) of all neonates hospitalized in our neonatal intensive care unit (NICU) who developed Acinetobacter infection to identify mortality-associated risk factors in Acinetobacter neonatal infection. "
04/01/2013 - "This study was designed to evaluate the results of the patients who developed Acinetobacter infection in the ICU after liver transplantation. "
04/01/2013 - "Acinetobacter infection in a liver transplantation intensive care unit."
04/01/2013 - "Acinetobacter infections in the ICU after liver transplantation were asociated with a high mortality presenting with thrombocytopenia."
10/01/1991 - "Children receiving antibiotic prophylaxis had also significantly more Enterococcus and Acinetobacter infections (P less than 0.001), and children with urinary catheters had more Enterobacter infections (P less than 0.05). "
12/01/1996 - "In four patients with refractory peritonitis (Candida infection in three, Acinetobacter infection in one), the nitrite levels remained elevated 2-fold despite treatment, and the catheters were removed. "
11/01/1999 - "There was a yearly median of 7.2 infections (range, 5.0-10.5) per 10,000 patient-days and a downward trend in the rate of acinetobacter infections overall (P<.05) and of 2 major types of infection (P<.05): bloodstream infections (yearly median, 1.6 per 10, 000 central venous catheter-days; range, 1.3-2.9) and pneumonia (yearly median, 7.6 per 10,000 ventilator-days; range, 6.5-12.0). "
|4.||Intensive Care (Surgical Intensive Care)
11/01/2000 - "Acinetobacter infection in neurosurgical intensive care patients."
11/01/1994 - "All the patients were surgical intensive care unit residents and had predisposing factors for acinetobacter infection. "
02/01/2014 - "Trauma is associated with a better prognosis in intensive care patients with Acinetobacter infections."
|5.||Prostheses and Implants (Prosthesis)
02/01/2014 - "Complications were: reflex sympathetic dystrophy (n=2), postoperative Acinetobacter infection (n=1) requiring revision to clean and drain allowing preservation of the prosthesis, and early postoperative anterior dislocation (n=1) (10° stem anteversion) with surgical revision to re-orient the stem. "
10/01/2006 - "Complications were: reflex sympathetic dystrophy (n=2), postoperative Acinetobacter infection (n=1) requiring revision to clean and drain allowing preservation of the prosthesis, and early postoperative anterior dislocation (n=1) (10 degrees stem anteversion) with surgical revision to re-orient the stem. "